Background -Pulmonary disease is a major contributor to morbidity and mortality in patients with HIV infection and AIDS. The aim of this study was to describe bronchoscopic findings and the spectrum of pulmonary pathogens in HIV seropositive patients undergoing investigation ofrespiratory disease over a 10 year period in a major UK referral centre. Methods -Recruitment was procedure based with data being captured when bronchoscopy was clinically indicated. Data were evaluated from 580 HIV seropositive patients (559 men, age 13-65 years) over a 10 year period from June 1983 to March 1993. Results -A total of947 bronchoscopies was performed. The most frequent pulmonary pathogen isolated from bronchoalveolar lavage (BAL) fluid in 44% of all bronchoscopies was Pneumocystis carinii. Of
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Background -Pulmonary disease is a major contributor to morbidity and mortality in patients with HIV infection and AIDS. The aim of this study was to describe bronchoscopic findings and the spectrum of pulmonary pathogens in HIV seropositive patients undergoing investigation ofrespiratory disease over a 10 year period in a major UK referral centre. Methods -Recruitment was procedure based with data being captured when bronchoscopy was clinically indicated. Data were evaluated from 580 HIV seropositive patients (559 men, age 13-65 years) over a 10 year period from June 1983 to March 1993. Results -A total of947 bronchoscopies was performed. The most frequent pulmonary pathogen isolated from bronchoalveolar lavage (BAL) fluid in 44% of all bronchoscopies was Pneumocystis carinii. Of all patients studied, 324 (55%) had at least one cytologically confirmed episode of P carinii pneumonia; this was AIDS defining in 219 (38%) of patients who underwent bronchoscopy. Between 1987 and 1993 the overall diagnostic yield from BAL fluid was 76%; 25% ofall bronchoscopies yielded positive microbiological results, the most frequent isolates being Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas spp, and Haemophilus influenzae. Mycobacteria were identified in 8% of patients; M tuberculosis was the most common being identified in 3% of lavage samples and in 4% of patients. No Fibreoptic bronchoscopy was performed in standard fashion. Arterial oxygen saturation was monitored and supplemental oxygen delivered as required. After segmental and subsegmental inspection to evaluate the presence of endobronchial Kaposi's sarcoma, the bronchoscope was wedged in the medial segment ofthe middle lobe or in the segmental bronchus corresponding to the area of maximal radiographic abnormality. Bronchoalveolar lavage was performed by instillation of up to four sequential 60 ml aliquots of sterile isotonic saline warmed to 37°C and then removed under low pressure and pooled in a 500 ml polypropylene bottle. All BAL specimens were evaluated for bacteria, fungi, and mycobacteria by conventional Fungal isolates in BAL fluid were found in 83 instances of which Candida spp were clearly predominant (n = 67) but of unlikely clinical significance. Pulmonary isolates of Aspergillus spp were rare (n = 9), as were those of Cryptococcus spp (n = 3). In one patient, a resident in the USA, Histoplasma capsulatum was isolated on two occasions.
MYCOBACTERIA
Between 1987 and 1993 mycobacteria were isolated in 63 of 834 (7 5%) samples of BAL fluid with annual prevalence rates between 5% and 13%. Of the mycobacterial pathogens isolated, M tuberculosis was the commonest, occurring in 23 This approach is open to criticism as the bronchoscopic findings were not prospectively evaluated in conjunction with clinical indices of disease progression, regression, specific therapeutic intervention, or outcome but, as already stated, the aim of this study was simply to evaluate the clinical usefulness of bronchoscopy in routine clinical practice. Furthermore, a general problem with all clinical studies of diagnostic yields for P carinii pneumonia by bronchoscopy is the case definition. As confirmatory open lung biopsies or necroscopic examinations are rarely available, the denominator will always include unconfirmed cases that were clinically typical, responded appropriately to specific therapy, and where no alternative diagnosis emerged. A problem with this is that cases of pneumonia responsive to co-trimoxazole may include some bacterial cases.
Bearing these reservations in mind, most bronchoscopic studies previously reported"'-' were conducted during the early years of the HIV epidemic and contained data on fewer patients than the present study. The larger previous studies' 14 have shown both the high diagnostic accuracy and sensitivity and the high negative predictive value (or low false negative rate) of both BAL and transbronchial biopsy. This study confirms previous observations that P carinii pneumonia is still the most important pulmonary complication. Our findings also support the limited additional information obtained by transbronchial biopsy.'-'" Finally, our overall frequency of isolation of pulmonary pathogens from BAL fluid is in line with others'4 at 76%, although annual trends did fluctuate.
Over the last 10 years P carinii has been identified in respiratory tract specimens in 55% of all HIV seropositive patients undergoing bronchoscopy, providing the index AIDS defining diagnosis in 219 (38%) of these patients. For the last seven completed years between 35% and 60% of all bronchoscopies annually were positive for P carinii pneumonia (fig 3) with a mean of 47%, and over the last four years (1989-92) there has been no trend towards a decline, despite widespread use of zidovudine and prophylaxis, which confirms a similar recent observation. '6 Bacterial infections are common in HIV infected patients. '7 In an early series, Murray et all reported that 2-5% of patients with HIV pulmonary disorders had bacterial infection. In the current study, largely of homosexual or bisexual men containing very few intravenous drug abusers, although Str pneumoniae and H influenzae were common, it is interesting that Staph aureus was the most common bacterial isolate. In several studies Staph aureus has not been reported as a frequent cause of pneumonia' 16`19 whereas other series have reported staphylococcal pneumonia in HIV disease in up to 8%,20-22 often occurring in association with pulmonary Kaposi's sarcoma or P carinii pneumonia -observations which our data support.
Our data also suggest a trend towards an increase in bacterial yields from BAL fluid over the study period, an observation in line with that of Pitkin et al. 6 However, these yields may be an underestimation due to antibiotic therapy before bronchoscopy. This The incidence of bronchoscopically visualised endobronchial Kaposi's sarcoma between 1987 and 1993 was 15% amongst all patients and 12% amongst all procedures, with annual rates since 1988 fluctuating between 10% and 16%. Almost all patients with endobronchial Kaposi's sarcoma had evidence of extrapulmonary disease.
The final point to address relates to trends in workload with respect to patient requirements for bronchoscopy, and the implications that this may have for future health care provision and resource planning. Our data suggest that at least 30% of all patients with HIV infection will, at some stage, need a bronchoscopy.
In conclusion, this retrospective analysis presents data from a 10 year period in patients with HIV infection who received their clinical care at a principal UK referral centre. The data reflect routine respiratory clinical practice and the findings are purely descriptive, based on routine laboratory analysis of BAL fluid obtained at bronchoscopy. Our analysis over time has allowed some observations of minor trends in the important pulmonary diagnostic categories within the spectrum of HIV infection. Such data acquisition is important in defining future health care needs, clinical care supervision, and research priorities.
